Tissue concentration of systemically administered antineoplastic agents in human brain tumors

od Pitz, Marshall W., Desai, Arati, Grossman, Stuart A., Blakeley, Jaishri O.
Izdano 2011

PATH-25. EXPERIENCE WITH AN RNA FUSION TRANSCRIPT PANEL FOR DETECTION OF POTENTIAL THERAPEUTIC TARGETS IN GLIOMAS

od Kothari, Shawn, Bagley, Stephen, Desai, Arati, Morrisette, Jennifer, Sussman, Robyn, MacLean, Nasrallah
Izdano u Neuro Oncol (2020)

PATH-02. USE OF RNAseq TO IDENTIFY TUMOR CELL AND MICROENVIRONMENT FACTORS ASSOCIATED WITH IMMUNE CYTOLYTIC ACTIVITY IN GLIOBLASTOMA

od Bagley, Stephen J, O’Rourke, Donald M, Brem, Steven, Linette, Gerald P, Desai, Arati S
Izdano u Neuro Oncol (2017)

Multiparametric MRI assessment of response to convection-enhanced intratumoral delivery of MDNA55, an interleukin-4 receptor targeted immunotherapy, for recurrent glioblastoma

od Mohan, Suyash, Wang, Sumei, Chawla, Sanjeev, Abdullah, Kalil, Desai, Arati, Maloney, Eileen, Brem, Steven
Izdano u Surg Neurol Int (2021)

Obesity, Mammography Use and Accuracy, and Advanced Breast Cancer Risk

od Kerlikowske, Karla, Walker, Rod, Miglioretti, Diana L., Desai, Arati, Ballard-Barbash, Rachel, Buist, Diana S. M.
Izdano 2008

CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges

od Bagley, Stephen J, Desai, Arati S, Linette, Gerald P, June, Carl H, O’Rourke, Donald M
Izdano u Neuro Oncol (2018)

Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck

od BAUMAN, JESSICA, LANGER, COREY, QUON, HARRY, ALGAZY, KENNETH, LIN, ALEXANDER, DESAI, ARATI, MUTALE, FAITH, WEISS, JARED
Izdano 2013

PATH-41. PLASMA CELL-FREE DNA (cfDNA) CONCENTRATION IS INDEPENDENTLY ASSOCIATED WITH RADIOGRAPHIC TUMOR BURDEN IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PRIOR TO INITIAL SURGICAL RESEC...

od Bagley, Stephen, Till, Jacob, Mays, Jazmine, Nabavizadeh, Seyed, Yee, Stephanie, Levy, Scott, Desai, Arati, Carpenter, Erica
Izdano u Neuro Oncol (2018)

A dual-genotype oligoastrocytoma with histologic, molecular, radiological and time-course features

od Nasrallah, Mac Lean P., Desai, Arati, O’Rourke, Donald M., Surrey, Lea F., Stein, Joel M.
Izdano u Acta Neuropathol Commun (2020)

PATH-40. TARGETED NEXT GENERATION SEQUENCING (NGS) OF YOUNG ADULTS WITH ISOCITRATE-DEHYDROGENASE WILD-TYPE GLIOBLASTOMA (IDH-WT GBM) REVEALS NEGATIVE PROGNOSTIC IMPACT OF EPIDERMAL...

od Hoffman, Daniel, Abdullah, Kalil, Binder, Zev, O’Rourke, Donald, Desai, Arati, Morrissette, Jennifer, Brem, Steven, Bagley, Stephen
Izdano u Neuro Oncol (2018)

RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastoma

od Bagley, Stephen J., Hwang, Wei-Ting, Brem, Steven, Linette, Gerald P., O’Rourke, Donald M., Desai, Arati S.
Izdano u J Neurooncol (2018)

2137 Percentage of viable tumor Versus radiation treatment effect in surgical specimens is not associated with outcomes in recurrent glioblastoma

od Schwab, Robert D., Bagley, Stephen, Binder, Zev, Lustig, Robert, O’Rourke, Donald, Brem, Steven, Desai, Arati S., Nasrallah, MacLean
Izdano u J Clin Transl Sci (2018)

RBTT-05. A SINGLE-ARM, OPEN-LABEL, PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF ABEMACICLIB IN PATIENTS WITH RECURRENT OLIGODENDROGLIOMA: TRIALS IN PROGRESS

od Bagley, Stephen, Nasrallah, MacLean, O’Rourke, Donald, Hussain, Jasmin, Maloney-Wilensky, Eileen, Prior, Timothy, Brem, Steven, Desai, Arati
Izdano u Neuro Oncol (2019)

RBTT-12. A PHASE I STUDY OF EGFRVIII-DIRECTED CAR T CELLS COMBINED WITH PD-1 INHIBITION IN PATIENTS WITH NEWLY, DIAGNOSED, MGMT-UNMETHYLATED GLIOBLASTOMA: TRIAL IN PROGRESS

od Bagley, Stephen, Desai, Arati, Binder, Zev, Nasrallah, MacLean, Hwang, Wei-Ting, Maloney-Wilensky, Eileen, Prior, Timothy, Brem, Steven, O’Rourke, Donald
Izdano u Neuro Oncol (2019)

ACTR-15. SAFETY AND PRELIMINARY ACTIVITY OF PT2385, A FIRST-IN-CLASS HIF2-ALPHA INHIBITOR, PLANNED INTERIM ANALYSIS OF AN OPEN LABEL, SINGLE-ARM PHASE II STUDY IN PATIENTS WITH REC...

od Strowd, Roy, Ellingson, Benjamin, Wen, Patrick, Ahluwalia, Manmeet, Piotrowski, Anna, Desai, Arati, Clarke, Jennifer, Lieberman, Frank, Desideri, Serena, Nabors, L Burt, Grossman, Stuart
Izdano u Neuro Oncol (2018)

Microvesicles as a Biomarker for Tumor Progression versus Treatment Effect in Radiation/Temozolomide-Treated Glioblastoma Patients

od Koch, Cameron J., Lustig, Robert A., Yang, Xiang-Yang, Jenkins, Walter T., Wolf, Ronald L., Martinez-Lage, Maria, Desai, Arati, Williams, Dewight, Evans, Sydney M.
Izdano u Transl Oncol (2014)

Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients

od Evans, Sydney M., Putt, Mary, Yang, Xiang-Yang, Lustig, Robert A., Martinez-Lage, Maria, Williams, Dewight, Desai, Arati, Wolf, Ronald, Brem, Steven, Koch, Cameron J.
Izdano u J Neurooncol (2016)

ATIM-21. UPDATED RESULTS OF A PHASE I TRIAL OF ANTI-LAG-3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM

od Lim, Michael, Ye, Xiaobu, Nabors, L Burt, Piotrowski, Anna, Ahluwalia, Manmeet, Desai, Arati, Walbert, Tobias, Fisher, Joy, Desideri, Serena, Sims, Megan, Wen, Patrick, Grossman, Stuart
Izdano u Neuro Oncol (2018)

BIMG-12. [18F]FLUCICLOVINE PET TO DISTINGUISH PSEUDOPROGRESSION FROM TUMOR PROGRESSION IN POST-TREATMENT GLIOBLASTOMA

od Nabavizadeh, Ali, Doot, Robert, Young, Anthony, Nasrallah, MacLean, Ware, Jeffrey, Schubert, Erin, Henderson, Fraser, Pantel, Austin, Desai, Arati, Bagley, Stephen, O’Rourke, Donald, Brem, Steven
Izdano u Neurooncol Adv (2021)

Three‐dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma

od Verma, Gaurav, Chawla, Sanjeev, Mohan, Suyash, Wang, Sumei, Nasrallah, MacLean, Sheriff, Sulaiman, Desai, Arati, Brem, Steven, O'Rourke, Donald M., Wolf, Ronald L., Maudsley, Andrew A., Poptani, Harish
Izdano u NMR Biomed (2018)